Search Results 51-60 of 17566 for Menses

  1. Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer - Mayo Clinic

    No spontaneous menses ≥ 1 year or; No menses for < 1 year with follicle stimulating hormone (FSH) and estradiol levels in postmenopausal range, according to ...

  2. A Study to Evaluate Blood Chemistry, Genetics, and Eye Exams in Women with Polycystic Ovary Syndrome and/or Idiopathic Intracranial Hypertension - Mayo Clinic

    Participants that have >9 menses per year who meet other PCOS criteria will be given option of having progesterone test drawn between days 20 and 22 of ...

  3. Extended-cycle birth control pills: Is spotting common? - Mayo Clinic

    Bleeding that's like a period happens while taking the inactive pills. An extended-cycle pill pack contains hormone pills that you take for longer than a month.

  4. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery - Mayo Clinic

    no spontaneous menses ≥ 1 year or; no menses for < 1 year with follicle-stimulating hormone (FSH) and estradiol levels in postmenopausal range, according to ...

  5. Metronidazole (vaginal route) - Side effects & dosage - Mayo Clinic

    Metronidazole vaginal is used to treat women with vaginal infections (eg, bacterial vaginosis). Metronidazole belongs to the class of medicines known as ...

  6. A Study to Evaluate Olaparib and Temozolomide in Treating Patients With Advanced, Metastatic, or Unresectable Uterine Leiomyosarcoma - Mayo Clinic

    Radiation-induced oophorectomy with last menses > 1 year ago;; Chemotherapy-induced menopause with > 1 year interval since last menses;; Surgical ...

  7. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

    * Radiation-induced oophorectomy with last menses \>1 year ago * Chemotherapy-induced menopause with \>1 year interval since last menses * Bilateral ...

  8. A Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy - Mayo Clinic

    ... menses with a follicle stimulating hormone level > 40 IU/L or ≥ 5 years since last regular menses, confirmed before any study drug is administered).

  9. Venetoclax In Combination With ASTX727 For The Treatment Of Chronic Myelomonocytic Leukemia And Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm - Mayo Clinic

    - Radiation-induced oophorectomy with last menses > 1 year ago - Chemotherapy-induced menopause with > 1 year interval since last menses - Surgical ...

  10. A Study to Evaluate the Long-Term Safety of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    A postmenopausal state is defined as no menses for 12 months without an alternative medical cause. Exclusion Criteria: Any disease that may put the patient ...